Preventive Medicine: The Need of the Hour


  • Gundu HR Rao Director, Thrombosis Research, Lillehei Heart Institute University of Minnesota and Founder, CEO, of the South Asian Society on Atherosclerosis and Thrombosis.




It gives me great pleasure, to write this editorial for the International
Journal of Preventive Cardiology. To create awareness, develop,
awareness, educational, and preventive strategies, a professional
society, SASAT was established at the University of Minnesota in 1993.
Many international conferences have been organized worldwide and
several books have been published on this topic of great public health
interest.1-5 Despite the best efforts of the professional societies, global
health organizations, published guidelines and scientific statements,
the cardiometabolic diseases have increased in their prevalence and
incidence, to epidemic proportions worldwide.6-9 Nearly half of all the
adults in the United States, have some type of cardiovascular disease or
the other (CVD), defined as coronary artery disease, heart failure, stroke
or high blood pressure, according to the American Heart Association
(AHA)’s annual report, “Heart and Stroke Statistics-2019.”10 AHA data
shows, that more than 121 million adults had cardiovascular disease
in 2016, a number which is slowly on the rise. Seminal studies of
Framingham Heart Group described the risk factors for the development
of heart diseases half a century ago, yet vascular diseases are the
number one killer worldwide and have retained this status for over
a century. An estimated 18 million people died from CVDs in 2016,
representing 31% of all global deaths. Of these deaths, 85% were due
to heart attack and stroke.


Rao GHR: (Editor): Handbook of Platelet Physiology and Pharmacology, Kluwer Academic Publishers, Boston, 1999. ISBN # 0-7923-8538-1

Rao GHR: (Editor): Coronary Artery Disease in South Asians: Epidemiology, Risk Factors, Prevention. Jaypee Medical Publishers, New Delhi, India, 2001, ISBN #81-7179-811-X.

Rao GHR: (Editor): Coronary Artery Disease: Risk Factors, Pathophysiology and Prevention. Jaypee Medical Publishers, New Delhi, India. 2005, ISBN # 81-8061-450-6.

Rao GHR: (Editor): Handbook on Coronary Artery Disease, McMillan Medical Communications (Springer Healthcare), New Delhi, India. 2016.

Rao GHR: Manual of Blood Platelet Physiology and Pharmacology, JP Medical Publishers, New Delhi, India. 2018.

Rao GHR: Prevention or reversal of Cardiometabolic Diseases. J. Clin & Preventive Cardiology. 7 (1); 22-28, 2018.

Rao GHR: Predictive and Preventive Healthcare: Integration of Emerging Technologies. Point of View. J. Clin Res in Diab. & Endocrinol. 1(1): 1-8, 2018.

Rao GHR: Cardiometabolic Dieses: A global perspective. J of Cardiol Cardiovasc. Ther. 12 (2): JOCCT. MSID. 55834 (2018).

Rao GHR: Global Syndemic of Metabolic Diseases. Editorial. J. Diab & Clin Res. 1(1):2-4, 2018.

Benjamin EJ, Muntner P, Alonso S et al: Heart Disease and Stroke Statsitics-2019 Update: A Report of the American Heart Association Circ. 2019;139: e56-e528.

Di Cesare M, Bennett JE, Best N et al: The contributions of risk trends to cardiometabolic mortality decline in 26 industrialized countries. Int J Epid. 42 (3): 838-48, 2013.

Bernd Sebastian Kamps Christian Hoffman: COVID-REFERENCE:

Tian H, Liu Y et al: An investigation of transmission control measures for the first 50 days of the COBID-19 epidemic in China Science 2020.

Yusuf S, Hawken S, Ounpuu S et al: Effect of potentially modifiable risk factors associated with myocardial infraction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (9438):937-52, 2004.

Khera AV, Emdin CA, Drake I et al: Genetic risk, adherence to a healthy lifestyle, and coronary artery disease. N Engl. J. Med. 375:2349-2358, 2016.